Your browser doesn't support javascript.
loading
Imaging features of hepatic angiosarcoma: retrospective analysis of two centers.
Jiang, Lei; Xie, Lijun; Wu, Zhenheng; Ke, Qiming; Chen, Mo; Pan, Wei; Zhong, Fuxiu; Hong, Haijie; Chen, Jiangzhi; Cai, Xinran; Chen, Shun; Gan, Ling; Chen, Yanling.
Affiliation
  • Jiang L; Department of Hepatobiliary Surgery and Fujian Institute of Hepatobiliary Surgery, Fujian Medical University Cancer Center, Fujian Medical University Union Hospital, Fuzhou, 350001, Fujian Province, China.
  • Xie L; Key Laboratory of The Ministry of Education for Gastrointestinal Cancer, Fujian Medical University, Fuzhou, 350108, Fujian Province, China.
  • Wu Z; Fujian Key Laboratory of Tumor Microbiology, Department of Medical Microbiology, Fujian Medical University, Fuzhou, 350108, Fujian Province, China.
  • Ke Q; Department of Ultrasonic Image, The First Affiliated Hospital, Fujian Medical University, Fuzhou, 350005, Fujian Province, China.
  • Chen M; Department of Ultrasonic Image, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou, 350212, Fujian Province, China.
  • Pan W; Department of Hepatobiliary Surgery and Fujian Institute of Hepatobiliary Surgery, Fujian Medical University Cancer Center, Fujian Medical University Union Hospital, Fuzhou, 350001, Fujian Province, China.
  • Zhong F; Key Laboratory of The Ministry of Education for Gastrointestinal Cancer, Fujian Medical University, Fuzhou, 350108, Fujian Province, China.
  • Hong H; Fujian Key Laboratory of Tumor Microbiology, Department of Medical Microbiology, Fujian Medical University, Fuzhou, 350108, Fujian Province, China.
  • Chen J; Department of Hepatobiliary Surgery and Fujian Institute of Hepatobiliary Surgery, Fujian Medical University Cancer Center, Fujian Medical University Union Hospital, Fuzhou, 350001, Fujian Province, China.
  • Cai X; Key Laboratory of The Ministry of Education for Gastrointestinal Cancer, Fujian Medical University, Fuzhou, 350108, Fujian Province, China.
  • Chen S; Fujian Key Laboratory of Tumor Microbiology, Department of Medical Microbiology, Fujian Medical University, Fuzhou, 350108, Fujian Province, China.
  • Gan L; Department of Hepatobiliary Surgery and Fujian Institute of Hepatobiliary Surgery, Fujian Medical University Cancer Center, Fujian Medical University Union Hospital, Fuzhou, 350001, Fujian Province, China.
  • Chen Y; Key Laboratory of The Ministry of Education for Gastrointestinal Cancer, Fujian Medical University, Fuzhou, 350108, Fujian Province, China.
BMC Cancer ; 24(1): 1191, 2024 Sep 27.
Article in En | MEDLINE | ID: mdl-39333917
ABSTRACT

PURPOSE:

Identifying primary hepatic angiosarcoma (PHA) preoperatively is challenging, often relying on postoperative pathology. Invasive biopsy increases bleeding risk, emphasizing the importance of early PHA diagnosis through imaging. However, comprehensive summaries of ultrasound, abdominal computed tomography (CT), magnetic resonance imaging (MRI), and whole- body positron emission tomography-CT (PET-CT) in this context are lacking. This study aimed to investigate the comprehensive imaging characteristics of PHA. PATIENTS AND

METHODS:

Imaging data were collected from 7 patients diagnosed with PHA via pathology between January 2000 and December 2019 in two provincial grade III hospitals. All patients underwent routine color ultrasound examinations before surgery, with 3 patients receiving contrast-enhanced ultrasound (CEUS).CT scans, both plain and enhanced, were performed on 5 patients, and whole-body PET-CT examinations were conducted on 2 patients.

RESULTS:

Among the 7 patients with PHA, 4 presented with a single solid intrahepatic mass (2 of which were large), 1 with a single exophytic macroblock type, 1 with a mixed type featuring multiple masses and nodules, and 1 with a multiple nodule type. Conventional ultrasound of PHA showed uneven echoes within the tumor, potentially accompanied by septal zone echoes, and a blood flow grade of 0-I. CEUS displayed early-stage circular high enhancement, a central non-enhancement area, and a "vascular sign" around the tumor. CT scans revealed low-density shadows in the plain scan stage, high peripheral ring enhancement, and punctate nodular enhancement in the arterial phase, with varying intensities and the presence of a "vascular sign." During the portal vein stage, the interior of the tumor was consistently unfilled and exhibited structural disorder. PET-CT showed low-density lesions in the liver and low fluorodeoxyglucose metabolism.

CONCLUSIONS:

Imaging diagnosis plays a crucial role in PHA diagnosis. When liver tumor imaging matches the above characteristics, consider PHA.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Positron Emission Tomography Computed Tomography / Hemangiosarcoma / Liver Neoplasms Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: BMC Cancer Journal subject: NEOPLASIAS Year: 2024 Document type: Article Affiliation country: China Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Positron Emission Tomography Computed Tomography / Hemangiosarcoma / Liver Neoplasms Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: BMC Cancer Journal subject: NEOPLASIAS Year: 2024 Document type: Article Affiliation country: China Country of publication: United kingdom